Sturm, Ruger & Company (NYSE: RGR) has emerged as a focal point for investors following a dramatic spike in online searches related to a potential U.S. Department of Justice appeal of a recent National Firearms Act (NFA) ruling. According to Google Trends data, approximately 20,000 U.S. searches for the term “doj appeal nfa” were recorded over a nine-hour period on Thursday, representing a roughly 900% surge in search interest. The uptick in queries suggests growing market speculation about the future of firearm regulations, particularly those affecting suppressors and short-barreled rifles (SBRs).
The investor interest is directly tied to Ruger’s product portfolio. The company markets a range of suppressors under its RXD line, developed in collaboration with Dead Air Silencers, and launched three short-barreled rifle families in January. If the Texas federal court ruling stands, it could eliminate significant federal registration requirements for untaxed NFA items, potentially reducing paperwork and friction for buyers. This could stimulate demand for Ruger's suppressors and related firearms. However, an appeal could reinstate those regulatory hurdles, creating uncertainty for investors.
In the broader market context, U.S. cash markets were closed on Thursday, but the S&P 500 had closed at a record high of 7,798.99, up 0.7%, while small-cap stocks (Russell 2000) gained 0.2%. Ruger’s last verified stock price was $37.30 as of Wednesday afternoon, reflecting a slight decline of 0.40% from the prior session. In comparison, competitor Smith & Wesson Brands (NASDAQ: SWBI) traded at $14.11, down 0.77%.
The regulatory backdrop is pivotal. On August 5, a federal judge in Texas ruled that registration provisions could not be enforced for NFA items that are untaxed, following Congress's reduction of the transfer tax from $200 to zero effective January 1, 2026. This ruling covers suppressors, short-barreled rifles and shotguns, and certain other weapons. While the decision eliminates the federal transfer tax and eases registration requirements, standard background checks remain mandatory, and state-level restrictions still apply. The Department of Justice has not yet announced whether it will appeal the decision, leaving the regulatory landscape in flux.
Ruger’s exposure to these regulatory changes is significant. The company’s RXD22Ti suppressor, a small-caliber model, is priced at $499 MSRP, while the RXD30Ti long-range suppressor retails at $1,099. Additionally, Ruger offers compact versions of its popular PC Carbine, 10/22, and American Rifle Generation II, which are available in short-barreled rifle configurations. This product lineup positions Ruger to benefit directly from any reduction in regulatory burden.
The company’s financial performance has been robust. In the second quarter of 2026, Ruger reported net sales of $158.1 million, a 19% increase from $132.5 million in the same period last year. Adjusted diluted earnings per share rose to $0.52, up 27% from $0.41. Cash from operations reached $17.3 million. CEO Todd Seyfert attributed the outperformance to better factory execution and improved product availability, adding that the company “continued to outperform the broader market.”
Wall Street coverage remains limited, with only one analyst currently rating the stock. Lake Street’s Mark Smith reiterated a Buy rating after the earnings report and raised his price target to $46, implying a 23.3% upside from the recent price of $37.30. The consensus rating is Buy, with an average price target of $46.
Investors will be watching two key events in the coming week. First, any announcement from the Justice Department regarding an appeal or a request to stay the Texas ruling could significantly impact Ruger’s stock. Second, shareholders of record on August 14 are eligible for a quarterly dividend of $0.21, payable on August 28.
While the potential for reduced regulatory friction is a positive catalyst, risks remain. The ruling could be stayed or reversed on appeal, and state-level restrictions vary. Additionally, Ruger does not disclose suppressor or SBR revenue separately, making it difficult to quantify the near-term earnings impact. As such, investors should approach the stock with a balanced view, weighing the potential benefits against the uncertainties inherent in the regulatory process.
